Solid Biosciences Inc. SLDB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$56.74M-14.0% | -$49.79M-8.8% | -$45.78M-15.9% | -$39.48M-0.5% | -$39.28M+7.8% | ||
| $395K-15.4% | $467K+24.2% | $376K-2.6% | $386K-5.2% | $407K-16.6% | ||
| $5.15M-20.7% | $6.5M+65.5% | $3.93M+24.9% | $3.15M-5.9% | $3.34M-12.6% | ||
| -$47.23M+11.8% | -$53.56M-60.0% | -$33.47M+10.5% | -$37.41M-17.5% | -$31.85M-7.4% | ||
| $165K-70.8% | $565K+565% | $85K-77.5% | $377K+199% | $126K-38.2% | ||
| $44.76M— | —— | -$45.27M-38.3% | -$32.73M-19.2% | -$27.46M— | ||
| $0-100% | $203K-16.5% | $243K+71.1% | $142K+5.2% | $135K+5.5% | ||
| $239.03M+4,548% | $5.14M+337% | $1.18M— | $0-100% | $189.73M+2,634% | ||
| $236.56M+17,021% | -$1.4M+98.2% | -$77.57M-8.1% | -$71.75M-155% | $130.42M+722% | ||
| -$47.4M+12.4% | -$54.12M-61.3% | -$33.56M+11.2% | -$37.79M-18.2% | -$31.98M-7.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
